Back To Search Results

Clin Asst Prof Chiang Jianbang

MBBS (S’pore), MRCP (UK), MMed (Int Med)

Consultant

National Cancer Centre Singapore

Specialty: Medical Oncology, Medical Oncology

Clinical Interest: Lymphoma, Sarcoma, Skin ＆ Melanoma, Cancer Genomic Medicine, Hereditary/Familial Cancers

Conditions Treated by this Doctor:
Lymphoma Cancer, Melanoma, Sarcoma, Skin Cancer.

Clinical Appointments

Consultant SingHealth Duke-NUS Blood Cancer Centre
Consultant SingHealth Duke-NUS Genomic Medicine Centre
Consultant Division of Medical Oncology National Cancer Centre Singapore

Academic Appointments

Clinical Instructor at Duke-NUS Medical School

Profile

Dr Chiang Jianbang is a Consultant in Medical Oncology at the National Cancer Centre Singapore (NCCS). He focuses on cancer genetics in NCCS and works with a team of dedicated geneticist and genetic counsellors. He hopes to empower patients, family members and healthcare professionals with cancer genetics knowledge to improve personal and public health. His interests are in clinical cancer genetics, genomic medicine and implementation science.

Education

MMed (Int Med), National University of Singapore, 2013
MRCP, Royal College of Physician (UK), 2013
MBBS, National University of Singapore, 2009

Professional Appointments and Committee Memberships

Core Faculty, Singhealth Internal Medicine Residency Program
Physician Faculty, Singhealth Medical Oncology Residency Program

Awards

Nurturing Clinician Scientist Scheme, Singhealth Duke-NUS Academic Medical Centre 2020
DMO Sub-speciality grant, Singhealth Oncology Academic Clinical Program 2018
Junior Pitch for Funds, Singhealth Internal Medicine Academic Clinical Program 2015
Inspiring Resident-Educator Award, RiSE Awards 2015
Best Oral Presentation, IM Residents' Research Symposium 2014

Research Interests

Publications

1. Chiang J, Chia TH, Yuen J, et al: Impact of Variant Reclassification in Cancer Predisposition Genes on Clinical Care. JCO Precis Oncol 577–584, 2021

2. Chiang J, Ngeow J: The management of BRCA1 and BRCA2 carriers in Singapore. Chin Clin Oncol 9:62, 2020

3. Chiang J, Yang VS, Han S, et al: Minimizing transmission of COVID-19 while delivering optimal cancer care in a National Cancer Centre. J Cancer Policy 25:100241, 2020

4. Chiang J, Yuen J, Shaw T, et al: Predictive Testing for Tumor Predisposition Syndromes in Pediatric Relatives: An Asian Experience. Front Pediatr 8:568528, 2020